Author:
Scuffham Paul A.,Nikles Jane,Mitchell Geoffrey K.,Yelland Michael J.,Vine Norma,Poulos Christopher J.,Pillans Peter I.,Bashford Guy,del Mar Chris,Schluter Philip J.,Glasziou Paul
Publisher
Springer Science and Business Media LLC
Reference27 articles.
1. Centre for Disease Control and Prevention. The Burden of Chronic Diseases and their Risk Factors: National and State Perspectives 2004. 2004; www.cdc.gov/NCCDPHP/burdenbook2004/ . Accessed March 8, 2010.
2. Chodick G, Heymann A, Wood F, Kokia E. The direct medical costs of diabetes in Isreal. Eur J Health Econ. 2005;6(2):166–171.
3. Guyatt G, Keller L, Jaeschke R, Rosenbloom D, Adachi J, Newhouse M. The N-of-1 randomized controlled trial: clinical usefulness. Our three-year experience. Ann Intern Med. 1990;112(4):293–299.
4. Guyatt G, Sackett D, Taylor D. Determining optimal therapy. Randomized trials in individual patients. N Engl J Med. 1986;314(14):889–892.
5. Kravitz R, Duan N, Niedzinski E, Hay M, Subramanian S, Weisner T. What ever happened to N-of-1 trials? Insiders’ perspectives and a look to the future. Milbank Q. 2008;86(4):533–555.
Cited by
79 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献